eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | neurofibromatosis |
| Symptom | C0027809|schwannomas |
| Sentences | 14 |
| PubMedID- 24349188 | Five patients after bvds for bilateral vestibular schwannomas due to neurofibromatosis type ii (4 females and 1 male, age range = 39–60 years, m = 46.4 years, sd = 8.2), who did not have any functioning ear were tested with monocular dual-search coils in ludwig-maximilians university . |
| PubMedID- 23407292 | Conservative management of bilateral vestibular schwannomas in neurofibromatosis type 2 patients: hearing and tumor growth results. |
| PubMedID- 23546912 | Cerebral hernia caused by a thoracic surgery for multiple schwannomas in a patient with neurofibromatosis type 2. |
| PubMedID- 23060586 | Both patients developed solitary schwannomas-only, without any hint of type 2 neurofibromatosis or schwannomatosis during a follow-up of several years. |
| PubMedID- 23225215 | They are usually solitary and encapsulated masses, but multiple schwannomas may be associated with neurofibromatosis type 2. the tumour may grow through the adjacent intervertebral foramen and spinal canal to produce a “dumbbell” or “hourglass” configuration. |
| PubMedID- 22483820 | The focus is on management of sporadic, unilateral vestibular schwannomas, because patients with neurofibromatosis type 2 pose different management problems best discussed separately. |
| PubMedID- 24718755 | Audiovestibular characteristics of small cochleovestibular schwannomas in neurofibromatosis type 2. |
| PubMedID- 20150363 | Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2. |
| PubMedID- 22004800 | Bevacizumab treatment for vestibular schwannomas in neurofibromatosis type two: report of two cases, including responses after prior gamma knife and vascular endothelial growth factor inhibition therapy. |
| PubMedID- 20406973 | Patients with bilateral vestibular schwannomas associated with neurofibromatosis type 2 (nf2) experience significant morbidity such as complete hearing loss. |
| PubMedID- 21926040 | Multiple cutaneous plexiform schwannomas revealing neurofibromatosis type 2 in a child - report of a novel mutation in this rare association. |
| PubMedID- 26377980 | Strategy for the surgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2. |
| PubMedID- 22681725 | Additionally, this method of drug delivery may have important implications in the treatment of patients with vestibular schwannomas associated with neurofibromatosis type 2. |
| PubMedID- 24393766 | Two phase ii clinical trials (nct01207687, nct01125046) are assessing the effectiveness of bevacizumab in treating neurofibromatosis 2 patients with symptomatic vestibular schwannomas and recurrent or progressive meningiomas. |
Page: 1